Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

VODSKOV DYREKLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.4% 4.3% 2.3% 1.3% 1.0% 1.6% 8.5% 8.3%   Credit score (0-100)   55 49 64 78 86 73 29 30   Credit rating   BBB BBB BBB A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 36.7 238.3 6.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,795 4,613 5,287 5,621 6,829 8,414 0.0 0.0   EBITDA   320 -85.5 875 1,382 1,251 506 0.0 0.0   EBIT   -65.2 -401 578 1,068 990 212 0.0 0.0   Pre-tax profit (PTP)   -54.2 -420.4 576.4 1,071.1 991.3 156.1 0.0 0.0   Net earnings   -44.2 -328.3 452.0 836.3 775.5 133.2 0.0 0.0   Pre-tax profit without non-rec. items   -54.2 -420 576 1,071 991 156 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   962 831 943 747 938 4,957 0.0 0.0   Shareholders equity total   1,116 788 1,240 1,876 2,252 1,796 1,716 1,716   Interest-bearing liabilities   257 540 66.7 0.0 210 4,771 0.0 0.0   Balance sheet total (assets)   2,437 2,692 3,683 3,443 3,922 8,444 1,716 1,716   Net Debt   248 538 -884 -186 -183 4,561 -1,678 -1,678     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,795 4,613 5,287 5,621 6,829 8,414 0.0 0.0   Gross profit growth   12.2% 21.6% 14.6% 6.3% 21.5% 23.2% -100.0% 0.0%   Employees   8 11 11 12 14 20 0 0   Employee growth %   33.3% 37.5% 0.0% 9.1% 16.7% 42.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,437 2,692 3,683 3,443 3,922 8,444 1,716 1,716   Balance sheet change%   -6.5% 10.4% 36.8% -6.5% 13.9% 115.3% -79.7% 0.0%   Added value   320.1 -85.5 874.6 1,381.8 1,303.6 506.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -403 -425 -232 -544 -75 3,719 -4,957 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.7% -8.7% 10.9% 19.0% 14.5% 2.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.1% -15.2% 18.6% 30.3% 27.0% 3.8% 0.0% 0.0%   ROI %   -3.5% -27.6% 42.1% 65.5% 45.9% 5.2% 0.0% 0.0%   ROE %   -3.4% -34.5% 44.6% 53.7% 37.6% 6.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.8% 29.3% 33.7% 54.5% 57.4% 21.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   77.3% -629.6% -101.0% -13.4% -14.6% 901.0% 0.0% 0.0%   Gearing %   23.0% 68.6% 5.4% 0.0% 9.3% 265.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.6% 8.0% 5.5% 26.0% 4.0% 3.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.9 1.1 1.1 0.3 0.0 0.0   Current Ratio   1.0 0.9 1.1 1.5 1.6 0.5 0.0 0.0   Cash and cash equivalent   8.9 2.0 950.4 185.7 392.2 209.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   28.6 -209.2 231.0 764.5 954.9 -3,635.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   40 -8 80 115 93 25 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   40 -8 80 115 89 25 0 0   EBIT / employee   -8 -36 53 89 71 11 0 0   Net earnings / employee   -6 -30 41 70 55 7 0 0